{"id":"amlodipine-high","safety":{"commonSideEffects":[{"rate":"6.2%","effect":"Edema"},{"rate":"4.8%","effect":"Dizziness"},{"rate":"3.7%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200402","moleculeType":"Small molecule","molecularWeight":"567.06"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amlodipine is a dihydropyridine calcium channel blocker that inhibits the influx of calcium ions into vascular smooth muscle and cardiac muscle.","oneSentence":"Calcium channel blocker","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:08:52.780Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina"}]},"trialDetails":[{"nctId":"NCT07240909","phase":"PHASE4","title":"Antihypertensive Drug Selection Based on Hemodynamic Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-01","conditions":"Hypertension","enrollment":240},{"nctId":"NCT05103332","phase":"PHASE2","title":"Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)","status":"COMPLETED","sponsor":"Alnylam Pharmaceuticals","startDate":"2021-11-05","conditions":"Hypertension","enrollment":663},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT03938389","phase":"PHASE4","title":"The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2020-02-25","conditions":"PreDiabetes, Impaired Glucose Tolerance, Obesity","enrollment":90},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT06942377","phase":"PHASE2","title":"Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-07-15","conditions":"Endometrial Cancer","enrollment":140},{"nctId":"NCT06625346","phase":"","title":"Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.","status":"RECRUITING","sponsor":"The Searle Company Limited Pakistan","startDate":"2024-09-28","conditions":"Hypertension","enrollment":420},{"nctId":"NCT03264352","phase":"PHASE4","title":"Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes","status":"RECRUITING","sponsor":"XueQing Yu","startDate":"2018-02-01","conditions":"Diabetes Mellitus, Type 2, Adverse Event, Blood Pressure","enrollment":11414},{"nctId":"NCT06012487","phase":"PHASE1","title":"Correlates and Control of Blood Pressure Variability","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-05-01","conditions":"Blood Pressure Variability","enrollment":10},{"nctId":"NCT06780865","phase":"NA","title":"Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2025-01-30","conditions":"Chronic Kidney Disease(CKD), Nocturnal Hypertension","enrollment":200},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT06212648","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2022-03-25","conditions":"Hypertension, Essential Hypertension","enrollment":253},{"nctId":"NCT00171002","phase":"PHASE3","title":"Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-11","conditions":"Hypertension","enrollment":936},{"nctId":"NCT00170950","phase":"PHASE3","title":"Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension","status":"TERMINATED","sponsor":"Novartis","startDate":"2003-10","conditions":"Hypertension","enrollment":11506},{"nctId":"NCT00409760","phase":"PHASE3","title":"Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.","status":"COMPLETED","sponsor":"Novartis","startDate":"2003-01","conditions":"Hypertension","enrollment":1930},{"nctId":"NCT02046395","phase":"PHASE4","title":"Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tulane University School of Medicine","startDate":"2012-01","conditions":"Type 2 Diabetes, Hypertension","enrollment":28},{"nctId":"NCT05475665","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-07-14","conditions":"Essential Hypertension","enrollment":157},{"nctId":"NCT05688098","phase":"PHASE1","title":"Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-09-23","conditions":"Healthy Volunteers","enrollment":44},{"nctId":"NCT05688085","phase":"PHASE1","title":"Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-10-18","conditions":"Healthy Volunteers","enrollment":44},{"nctId":"NCT05476354","phase":"PHASE3","title":"Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2022-07-05","conditions":"Essential Hypertension","enrollment":271},{"nctId":"NCT05165251","phase":"PHASE4","title":"Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2022-01-04","conditions":"Isolated Systolic Hypertension","enrollment":480},{"nctId":"NCT04978649","phase":"PHASE4","title":"Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal Substudy","status":"WITHDRAWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2021-09-01","conditions":"Diabetes Mellitus, Type 2, Blood Pressure","enrollment":""},{"nctId":"NCT04521582","phase":"NA","title":"Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of Nepal","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2021-04-27","conditions":"Hypertension,Essential","enrollment":1428},{"nctId":"NCT05470764","phase":"PHASE1","title":"Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers","status":"COMPLETED","sponsor":"Darnitsa Pharmaceutical Company","startDate":"2021-05-30","conditions":"Bioequivalence, Healthy Subjects","enrollment":52},{"nctId":"NCT03897868","phase":"PHASE2","title":"A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-03-21","conditions":"Hypertension","enrollment":248},{"nctId":"NCT04488978","phase":"PHASE2","title":"Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension","status":"COMPLETED","sponsor":"Handok Inc.","startDate":"2020-05-21","conditions":"Essential Hypertension","enrollment":440},{"nctId":"NCT05398393","phase":"NA","title":"An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment","status":"UNKNOWN","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2022-01-01","conditions":"Hepatitis B, Chronic, Lipid Disorder","enrollment":150},{"nctId":"NCT01996449","phase":"PHASE2","title":"The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2013-07","conditions":"Hypertension","enrollment":14},{"nctId":"NCT03657550","phase":"PHASE1","title":"Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects","status":"COMPLETED","sponsor":"Conjupro Biotherapeutics, Inc.","startDate":"2018-05-31","conditions":"Hypertension","enrollment":36},{"nctId":"NCT04218552","phase":"PHASE2","title":"Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Addpharma Inc.","startDate":"2020-02-25","conditions":"Hypertension,Essential","enrollment":176},{"nctId":"NCT00667719","phase":"PHASE3","title":"A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-06-05","conditions":"Essential Hypertension","enrollment":564},{"nctId":"NCT03474562","phase":"PHASE4","title":"High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2018-04-03","conditions":"ASCVD, Impaired Fasting Glucose, Hypertension","enrollment":100},{"nctId":"NCT00143234","phase":"PHASE3","title":"Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-05","conditions":"Hypertension, Hyperlipidemia","enrollment":1825},{"nctId":"NCT02034435","phase":"PHASE4","title":"Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2013-10","conditions":"Metabolic Syndrome","enrollment":44},{"nctId":"NCT02979197","phase":"PHASE3","title":"Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring Antihypertensives","status":"COMPLETED","sponsor":"Kitov Pharma Ltd","startDate":"2016-11-03","conditions":"Hypertension","enrollment":105},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT00745953","phase":"PHASE4","title":"Regression of Fatty Heart by Valsartan Therapy","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2007-08","conditions":"Metabolic Syndrome, Lipotoxicity","enrollment":""},{"nctId":"NCT00791258","phase":"PHASE4","title":"A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood Pressure","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2008-11","conditions":"Hypertension","enrollment":999},{"nctId":"NCT00891267","phase":"PHASE3","title":"Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","startDate":"2008-10","conditions":"Metabolic Syndrome, Hypertension","enrollment":60},{"nctId":"NCT00185133","phase":"PHASE3","title":"Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2005-05","conditions":"Hypertension","enrollment":1900},{"nctId":"NCT02172040","phase":"PHASE3","title":"Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive Therapy","status":"COMPLETED","sponsor":"Kitov Pharmaceuticals, Ltd.","startDate":"2014-06-26","conditions":"Hypertension","enrollment":152},{"nctId":"NCT03635125","phase":"PHASE4","title":"Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine","status":"COMPLETED","sponsor":"Trinity Hypertension & Metabolic Research Institute","startDate":"2010-08-30","conditions":"JNC 7 Stage 1 or 2 Hypertension","enrollment":40},{"nctId":"NCT03489317","phase":"","title":"Gut Microbiomes in Patients With Metabolic Syndrome","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2017-11-27","conditions":"Metabolic Syndrome","enrollment":1000},{"nctId":"NCT03024476","phase":"PHASE2","title":"Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2016-09-01","conditions":"Ischemic Stroke, Hypertension","enrollment":67},{"nctId":"NCT01252238","phase":"NA","title":"Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2010-06","conditions":"Insulin Sensitivity, Aortic Compliance, Diastolic Function","enrollment":24},{"nctId":"NCT03255551","phase":"","title":"Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-01-01","conditions":"Hypertension","enrollment":50},{"nctId":"NCT00170963","phase":"PHASE3","title":"Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Hypertension","enrollment":1018},{"nctId":"NCT00446524","phase":"PHASE3","title":"Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-02","conditions":"Hypertension","enrollment":403},{"nctId":"NCT00139555","phase":"PHASE4","title":"Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-07","conditions":"Hypertension, Left Ventricular Hypertrophy","enrollment":125},{"nctId":"NCT01994408","phase":"PHASE1, PHASE2","title":"Default BP Medication Intensification","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2013-11","conditions":"Hypertension","enrollment":3},{"nctId":"NCT01365481","phase":"PHASE3","title":"Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-08","conditions":"Hypertension, Chronic Kidney Disease","enrollment":150},{"nctId":"NCT01692301","phase":"PHASE2","title":"Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-12","conditions":"Hypertension","enrollment":454},{"nctId":"NCT02710552","phase":"PHASE4","title":"Low-dose Combination of Three Antihypertensive Drugs","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2016-04","conditions":"Arterial Hypertension","enrollment":100},{"nctId":"NCT01663233","phase":"PHASE3","title":"Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-08","conditions":"Essential Hypertension","enrollment":266},{"nctId":"NCT00805311","phase":"PHASE4","title":"Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis","status":"TERMINATED","sponsor":"Russian Cardiology Research and Production Center","startDate":"2009-04","conditions":"Carotid Artery Stenosis, Atherosclerosis, Stroke","enrollment":400},{"nctId":"NCT01922141","phase":"PHASE4","title":"Aliskiren Study of Safety and Efficacy in Senior Hypertensives","status":"WITHDRAWN","sponsor":"Novartis Pharmaceuticals","startDate":"2015-05","conditions":"Hypertension","enrollment":""},{"nctId":"NCT02261064","phase":"PHASE1","title":"Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2008-12","conditions":"Healthy","enrollment":32},{"nctId":"NCT02259777","phase":"PHASE1","title":"Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2007-09","conditions":"Healthy","enrollment":40},{"nctId":"NCT02194309","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2006-09","conditions":"Healthy","enrollment":24},{"nctId":"NCT00563901","phase":"","title":"Analyzing How Genetics May Affect Response to High Blood Pressure Medications","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2000-09","conditions":"Hypertension, Coronary Disease, Cerebrovascular Accident","enrollment":37939},{"nctId":"NCT01134393","phase":"PHASE3","title":"TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2010-05","conditions":"Hypertension","enrollment":502},{"nctId":"NCT01432106","phase":"PHASE1","title":"The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome","status":"WITHDRAWN","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Hypertension, Metabolic Syndrome","enrollment":""},{"nctId":"NCT01956786","phase":"PHASE2, PHASE3","title":"Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine","status":"UNKNOWN","sponsor":"Shenzhen Ausa Pharmed Co.,Ltd","startDate":"2013-09","conditions":"Essential Hypertension","enrollment":540},{"nctId":"NCT01848873","phase":"PHASE2, PHASE3","title":"Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine","status":"UNKNOWN","sponsor":"Shenzhen Ausa Pharmed Co.,Ltd","startDate":"2013-01","conditions":"Essential Hypertension","enrollment":756},{"nctId":"NCT01368536","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-05","conditions":"Hypertension, Stage 2 Hypertension, Diabetes","enrollment":975},{"nctId":"NCT00454662","phase":"PHASE4","title":"Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)","status":"COMPLETED","sponsor":"COLM Study Research Organization","startDate":"2007-04","conditions":"Hypertension, Cardiovascular Disease, Diabetes","enrollment":5141},{"nctId":"NCT01011660","phase":"PHASE4","title":"Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients","status":"UNKNOWN","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2007-10","conditions":"Essential Hypertension","enrollment":13542},{"nctId":"NCT00185120","phase":"PHASE4","title":"Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2005-09","conditions":"Hypertension","enrollment":152},{"nctId":"NCT00409643","phase":"PHASE3","title":"Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-01","conditions":"Hypertension","enrollment":1259},{"nctId":"NCT00241150","phase":"PHASE4","title":"Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome","status":"COMPLETED","sponsor":"Novartis","startDate":"2002-11","conditions":"Hypertension, Metabolic Syndrome","enrollment":80},{"nctId":"NCT00171535","phase":"PHASE3","title":"Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-10","conditions":"Hypertension","enrollment":130},{"nctId":"NCT01070043","phase":"PHASE4","title":"To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-06","conditions":"Hypertension, High Blood Pressure","enrollment":60},{"nctId":"NCT00417170","phase":"PHASE2","title":"Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic Syndrome","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-10","conditions":"High Blood Pressure, Metabolic Syndrome, Insulin Resistance","enrollment":48},{"nctId":"NCT00425373","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-11","conditions":"Essential Hypertension","enrollment":1474},{"nctId":"NCT00413049","phase":"PHASE3","title":"Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-01","conditions":"Hypertension","enrollment":698},{"nctId":"NCT00413413","phase":"PHASE3","title":"Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-01","conditions":"Hypertension","enrollment":1134},{"nctId":"NCT01197014","phase":"PHASE1","title":"A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-09","conditions":"Healthy","enrollment":72},{"nctId":"NCT00402103","phase":"PHASE3","title":"An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Hypertension","enrollment":556},{"nctId":"NCT00134160","phase":"PHASE4","title":"OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study","status":"COMPLETED","sponsor":"OSCAR Study","startDate":"2005-08","conditions":"Hypertension, Cardiovascular Diseases","enrollment":1000},{"nctId":"NCT00548067","phase":"PHASE3","title":"Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-09","conditions":"Hypertension","enrollment":111},{"nctId":"NCT00426478","phase":"PHASE4","title":"Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-11","conditions":"Hypertension","enrollment":80},{"nctId":"NCT00400777","phase":"PHASE4","title":"Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2006-08","conditions":"Hypertension","enrollment":460},{"nctId":"NCT00313547","phase":"PHASE4","title":"High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients","status":"TERMINATED","sponsor":"Montreal Heart Institute","startDate":"2006-04","conditions":"Hypertension","enrollment":40},{"nctId":"NCT00125463","phase":"PHASE3","title":"Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients","status":"UNKNOWN","sponsor":"The Japanese Society of Hypertension","startDate":"2001-09","conditions":"Hypertension, Cardiovascular Diseases","enrollment":3200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1428,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Amlodipine high placebo"],"phase":"phase_2","status":"active","brandName":"Amlodipine High","genericName":"Amlodipine High","companyName":"Handok Inc.","companyId":"handok-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Calcium channel blocker Used for Hypertension, Angina.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}